Tools
Upgrade to Pro 🌟

Upgrade for Pro stock ideas, Al signals, and more search.

Learn More

IDNA

iShares Genomics Immunology and Healthcare ETF · PSE

  • Category Equity
  • Expense Ratio 0.47%
  • Listing Date Jun 13, 2019
  • Volume 26,173.0
  • Market Cap (AUM) $131.78M

Performance

-6.43%

1W

-6.05%

1M

-6.42%

3M

-3.94%

6M

+0.94%

YTD

+14.07%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Moderna, Inc.MRNA6.39%
  • Revolution Medicines, Inc.RVMD5.60%
  • Sarepta Therapeutics, Inc.SRPT5.12%
  • Regeneron Pharmaceuticals, Inc.REGN4.75%
  • Merck & Co., Inc.MRK4.56%
  • Incyte CorporationINCY4.29%
  • GSK plcGSK4.15%
  • SanofiSAN3.75%
  • Roche Holding Ltd Dividend Right Cert.ROG3.72%
  • Exelixis, Inc.EXEL3.67%

Technical Analysis of IDNA 2024-11-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 43 suggesting a neutral stance, and a Technical Score of 26 reinforcing the bearish outlook. This combination signals caution for potential investors, as the prevailing trend appears to be negat...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.